Skip to content
Menu

Relay Therapeutics, Inc. RLAY

Full chart Compare
Set alert

Price alert · RLAY

All alert types
16.47 USD -0.80 (-4.63%)

Regular-session close

16.47 0.00 0.00%

After hours · Nov 17, 4:01 PM ET

16.39 Day range 17.42
6.25 52-week range 21.27
YTD
+94.68%
1 year
+148.79%

Revenue & Expenses

Revenue Profit Costs
Other Income$26.26MOther Operating Income$3.56MGross Profit$11.80MNet Loss$276.48MCost of Revenue$3.56MExpenses$318.09MSelling, General & Admin$56.71MResearch & Development$261.38MRevenue$15.36M

Latest period ending Dec 31, 2025 · select a line to chart its full history

RLAY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.36M10.01M25.55M1.38M3.03M
15.36M10.01M25.55M1.38M3.03M
-302.74M-385.67M-379.42M-310.95M-361.86M
-276.48M-337.71M-341.97M-290.51M-363.87M
-1.61-2.36-2.79-2.59-3.82
RLAY annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
85.35M126.41M146.44M154.37M282.70M
621.33M871.30M843.98M1.10B1.01B
54.27M93.50M91.98M149.55M110.64M
32.46M48.50M53.47M57.74M22.90M
567.06M777.79M752.00M950.22M897.81M
RLAY annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-235.46M-249.11M-300.32M-229.49M-74.41M
192.80M-41.08M257.63M-188.75M-479.51M
1.60M270.15M34.75M289.91M388.09M
-410.00K-2.02M-4.13M-9.06M-3.47M
-41.05M-20.04M-7.93M-128.32M-165.83M